Platelet factor 4 (PF4) is a multifunctional protein specific to platelets, synthesized in megakaryocytes and stored in alpha granules. This report of our work shows that PF4 potently inhibits human megakaryocyte colony formation in vitro. Colony formation by megakaryocyte progenitor cells from normal bone marrows was studied using the plasma clot culture system and indirect immunoperoxidase staining. Nonadherent mononuclear cells were co-cultured with various concentrations (0 to 20 pg/mL) of highly purified human PF4. Statistically significant inhibition of three classes of megakaryocyte progenitor cells, the mixed colony forming unit-megakaryocytes (mCFU-MK), the burst forming unit-megakaryocytes (BFU-MK), and the colony forming unit-megakaryocytes (CFU-MK), was seen at a PF4 UMAN megakaryocytopoiesis has been suggested to H be negatively regulated by a t least two classes of biologic molecules, the accessory cell-released products, such as interferons alfa and and tumor necrosis factor (TNF)? and the platelet-released products, including platelet derived growth factor,' type beta transforming growth factor (TGF-p):' and other platelet released glycoprotein.' The first class of biologic molecules seem to be nonspecific, because they are capable of inhibiting other hematopoietic progenitor cell growth as well as megakaryocytopoiesis. In contrast, some of the molecules of the second class of molecules have been suggested to be able to specifically inhibit megakaryocyte colony formation.'^^ In this study, we demonstrate that platelet factor 4 (PF4) is a potent inhibitor of human megakaryocyte progenitor cell proliferation and maturation, and may play a role in autoregulating human megakaryocyte development.
concentration of 2.5 pg/mL or greater. PF4 had no effect on erythroid (BFU-E) and granulocyte/macrophage (CFU-GM) colony formation except at high concentration (5 pg/mL for BFU-E and 10 pg/mL for CFU-GM). When a concentration of 5 pg/mL PF4 was added at various time points during marrow culture, a reduction of megakaryocyte colony formation also occurred. In the presence of PF4 2.5 pg or 5 pg/mL, the percentage of mature type of colonies was found to be decreased compared with cultures with no added PF4. These data demonstrate that PF4 inhibits both proliferation and maturation of megakaryocyte progenitor cells in vitro and suggest that PF4 may play a role in autoregulating human megakaryocytopoiesis. 0 1990-by The American Societyof Hematology.
preparation of PF4 (Fig I) . In one experiment, another source of human PF4 from American Diagnostica Inc (No. 434; New York, NY) was tested as compared with the PF4 of Diagnostica Stago.
Bone marrow cells were obtained from hematologically normal subjects undergoing surgery for benign lesions, and aplastic anemia serum was obtained from patients with severe bone marrow aplasia.
Megakaryocyte progenitor cells were assayed in a plasma clot culture system as previously described,'.''.'' with slight modification. Briefly, the culture system contained 10% bovine citrated plasma (Flow Laboratories), 1 % deionized bovine serum albumin (Sigma Chemical Co, St Louis, MO), 5% human peripheral blood leukocyte conditioned medium stimulated by phytohemagglutinin (PHA-LCM), mol/L 2-mercaptoethanol (Sigma), 0.34 mg/mL CaCI,, 10% aplastic anemia sera completely replaced the normal volume of human normal AB sera, and 2 x lo5 nonadherent mononuclear cells (NAMC) per milliliter in alpha-medium supplemented with 0.15 mg/mL glutamine, 20 pg/mL asparagine, 15 U/mL penicillin, and 15 pg/mL streptomycin (GIBCO, Grande Island, NY). Cultures were incubated for 12 days in a humidified incubator at 37OC with 5 % CO, and air.
PHA-LCM was prepared as follows: Normal peripheral blood was first centrifuged at 200g for I O minutes to remove the platelet-rich plasma, then diluted in alpha-medium. Mononuclear cells were separated by centrifugation in lymphocyte-separating medium (density 1.077; Eurobio-Paris, France), cultured (1 x lo6 cells/mL) in alpha-medium containing t % PHA (HA15; Wellcome Diagnostica, Dartford, England) with 6% normal AB serum and 4% fetal bovine serum (GIBCO). After 7 days, PHA-LCM was harvested by centrifugation, filter-sterilized, and stored at -8OOC until used.
The concentrations of PF4 in PHA-LCM and aplastic anemia serum have been detected using an enzyme-linked immunosorbent assay (ELISA) kit (Diagnostica Stago). PHA-LCM and aplastic anemia sera contained PF4 2 ng and 5 ng/mL, respectively. In fact, one milliliter of culture medium contained only 0.05 mL PHA-LCM and 0.1 mL aplastic anemia sera. The basic concentration of PF4 in culture medium was therefore believed to be too low to affect the experimental results.
Megakaryocyte colonies were identified directly in dishes by an indirect immunoperoxidase staining with a monoclonal antibody against the platelet glycoprotein IIb/IIIa complex. The endogenous peroxidase activity was quenched by incubating the clots in methanol containing 1.5% H202 for 1 hour at room temperature with continuous stirring.'.'' Classification of megakaryocyte progenitor cells and their resultant colonies has been previously des~ribed.'.''.'~~'~ Briefly, megakaryocyte progenitor cells were classified according to their proliferative potential into three classes: (1) the mixed colonyMegakaryocyte progenitor cell assay. forming unit-megakaryocytes (mCFU-MK), (2) the burst-forming unit-megakaryocytes (BFU-MK). and (3) the colony-forming unitmegakaryocytes (CFU-MK). An mCFU-MK-derived colony was defined as a cluster of twoor more megakaryocytes mixed with other hematopoietic A BFU-MK-derived colony was defined as being composed of at least 40 megakaryocytes with two or more different foci of development."'" whereas a CFU-MK-derived colony was defined as a cluster of three or more megakaryocytes.
Due to the fact that the majority of megakaryocyte colonies are derived from CFU-MK and the number of cells per colony varies in a large range, we divided these colonies into three subtypes: the large (greater than 20 cells). mean (I I to 20 cells). and small (3 to IO cells) types of colonies."
Morphologic classification of megakaryocyte colonies was made as previously described.'.'' Three morphologic types. the immature or proliferative type. the polyploidized type. and the cytoplasmic mature type. were classified according to the morphology of individual megakaryocytes. Briefly, the colonies of immature type were defined as the clusters consisting of lymphoid-like cells with small size and round nuclei. The colonies of polyploidized type were defined as being composed of megakaryocytes with multilobulated nuclei but without mature cytoplasma. whereas the colonies of mature type were defined as the clusters containing the megakaryocytes with polyploidized nuclei and mature cytoplasma. The large cell volume (diameter greater than 40") and cytoplasmic granulation with or without platelet formation around cells were considered as the main criteria of cytoplasmic maturation. Due to the fact that cell maturation is a gradual process. morphologically different megakaryocytes may be present in the same colony. In this condition, colony classification was made according to the morphology of the dominant cell population (ie. greater than 2/3).
Erythroid and granulomonocyric progenitor cell assay. Erythroid colony formation (BFU-E) was assayed using the same plasma clot culture system for megakaryocyte progenitor cells. except that PHA-LCM was replaced by 1 unit/mL erythropoietin (National Blood Transfusion Center, Paris, France). Granulocyte/ macrophage colony formation (CFU-GM) was assayed in an agar semisolid culture system in which 2 x 10' NAMC were plated in I mL of alpha-medium containing 15% fetal bovine serum. 0.3% agar (Difco). and 10% human placental conditioned medium. prepared as described by Schlunk and Schloyen." Cultures were incubated for 14 days at 37OC with 5% CO' and air in a humified incubator. CFU-GM-derived colonies were defined as clusters of at least 40 cells, and scored by inverted microscopy. whereas BFU-E-derived colonies were identified by benzidine-hematoxylin staining and defined as being composed of three clusters with at least 20 positive cells per cluster.
RESULTS
Eflect of PF4 on megakaryocyte progenitor cell proliferation and maturation. Figure 2 shows the suppressive effect of increasing concentrations of PF4 on megakaryocyte colony formation. Statistically significant inhibition of megakaryocyte colony formation was seen at PF4 concentrations of 2.5 rg/mL or greater. As indicated in Table I . PF4 inhibited the growth of three classes of megakaryocyte progenitor cells in a concentration-dependent fashion. Table 2 shows that PF4 has an effect on the size of CFU-MK-derived colonies. In the presence of PF4 (2.5 and 5 pg/mL). the numbers of colonies of large and mean types were significantly decreased as compared with control cultures.
The percent distribution of megakaryocyte colonies according to morphology of individual megakaryocytes is shown in Table 3 . The addition of PF4 resulted in a reduction in the number of mature type colonies and an increase in the number of immature type colonies. These results suggest that PF4 inhibits not only the proliferation but also the maturation of megakaryocyte progenitor cells and individual megakaryocytes.
To determine whether the presence of PF4 during the different days of culture affected colony formation, PF4 was added a t a concentration of 5 rg/mL on days 0, 3, 6, and 9 after initiation of culture. The results are shown in Fig 3. The inhibitory effect of PF4 on megakaryocyte colony formation was always present, even when PF4 was added to cultures on day 9.
To test the reversibility of inhibition of colony formation caused by PF4, bone marrow NAMC were pre-incubated with or without 5 pg/mL PF4 for 30 minutes, 6 hours, or 24 hours. The cells were then thoroughly washed, dispersed into a single-cell suspension, and plated in plasma clot in optimum conditions for megakaryocyte colony formation.
The preincubation with PF4 caused a significantly reduced megakaryocyte colony formation. As can be seen in Table 4 , an exposure of 30 minutes resulted in an approximately 90% inhibition, and a complete inhibition of megakaryocyte colony formation was seen after 6 or 24 hours' exposure to PF4. These results suggest that PF4 may rapidly and tightly bind to or associate with megakaryocyte progenitor cells in liquid medium and then cause an inhibition of colony formation in subsequent plasma clot culture.
It was interesting to note that the preincubation of PF4 also caused a similar inhibition of BFU-E and CFU-GM growth ( Table 4) . This inhibition seemed more potent than when PF4 was directly added into plasma clot culture (Fig  3) . Why the preincubation of PF4 inhibits colony formation more potently than the direct addition of PF4 is unclear a t present. One explanation is that, in a plasma clot system, the rapid formation of clot may make the binding of PF4 to progenitor cells relatively difficult. In this condition, higher Delayed addition of PF4 to bone marrow cultures.
Preincubation with PF4 before culture. concentrations of PF4 may be needed to facilitate its binding to cells.
To test our hypothesis that PF4 binds to cells during preincubation in liquid medium, an immunolabeling experiment was performed. NAMC (10 cells/mL) were preincubated with 5 pg/mL PF4 in the presence of 0.1% sodium azide at 4OC for 30 minutes. After two washings with alpha-medium, the cells were fixed with 2% paraformaldehyde for 10 minutes, deposited onto slides by cytocentrifugation, and exposed to a plyclonal anti-PF4 antibody (Diagnostica Stago). After further incubation with rhodamine-conjugated goat anti-rabbit IgG (Nordic Immunologic Lab, Tilburg, The Netherlands), the cells incubated without PF4 were negative. By contrast, 6% f 2% of the cells incubated with PF4 were immunofluorescently labeled by anti-PF4 antibody. Most of the positive cells were the size of lymphocytes. These observations suggest the rapid and tight binding of PF4 to some mononuclear cells, although the nature of these cells is unclear at present. Effect of PF4 on CFU-GM and BFU-E growth. Figure 2 also shows that PF4 had no effect on colony formation by CFU-GM except at high concentration (10 pg/mL), where an approximately 40% inhibition was found, but not to a significant level. PF4 at 2.5 pg/mL had no effect on BFU-E growth. However, increasing concentrations caused a progressive inhibition. At 5 pg/mL, an approximately 40% inhibition of BFU-E growth was found, while at 10 pg/mL, the number of BFU-E was significantly decreased as compared with control cultures.
In one experiment, the PF4 from American Diagnostica was found to have the identical effect on megakaryocyte development as compared with the PF4 from Diagnostica Stago (Table 5) .
DISCUSSION
Platelet factor 4 is an important megakaryocyte/plateletspecific protein that is released after stimulation. Until recently, knowledge about PF4 was still limited to its physiologic role in the related processes of coagulation, inflammation, and tissue repair. '6-22 In this study, we have found that human PF4 potently inhibits colony formation by megakaryocyte progenitor cells. This inhibition was concentration-dependent. Statistically significant suppression was seen at a PF4 concentration of 2.5 pg/mL or greater. Only at higher concentrations (5 pg/mL for BFU-E and 10 pg/mL for CFU-GM) did the inhibitory effect of PF4 on erythroid and granulocyte macrophage colony formation become apparent.
The addition of PF4 to marrow cultures resulted in a significant reduction of the numbers of colonies derived from different classes of megakaryocyte progenitor cells, especially the numbers of mCFU-MK-, BFU-MK-, and large CFU-MKAerived colonies. Furthermore, the inhibition by PF4 also occurred in cultures in which PF4 was added later on days 3,6, and 9. These data suggest that PF4 does inhibit both proliferation and maturation of megakaryocyte progenitor cells, and that there is a progressive loss of inhibition, most likely due to decline of the sensitive cells. These experiments, in combination with the preincubation experiments, lead to the conclusion that within the spectrum of megakaryocyte progenitor cells, the early ones seemed to be the most sensitive to the action of PF4.
To determine if PF4 inhibits the maturation of individual megakaryocytes, we studied the effect of PF4 on the percent distribution of morphologically different types of megakaryocyte colonies. When a concentration of 2.5 pg/mL or 5
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From Although we confirm the findings that PF4 inhibits megakaryocyte colony formation, our results are different from those described by Gewirtz et First, we have shown that a marked inhibition (greater than 50%) of megakaryocyte colony formation by PF4 only required a concentration of 2.5 pg/mL purified PF4. Second, we found that PF4 potently inhibits the proliferation and maturation of early (mCFU-MK and BFU-MK) and later (CFU-MK) progenitor cells, as well as the maturation of individual megakaryocytes. Finally, PF4 was found to be able to suppress colony formation by BFU-E and CFU-GM a t higher concentrations. The cause of the difference between Gewirtz et al's data and ours is unclear a t present. It is unlikely that it is due to the possible contamination of TGF-P in the PF4 preparation we used, but it is likely that it is due to our using a different culture system. The purity of the PF4 preparation used by us has been detected using a combination of Western blot with specific anti-TGF-P antibody and SDS-PAGE followed by sensitive silver staining. This PF4 preparation was highly purified and contained no TGF-P, an inhibitor of myeloid progenitor cells. We have noted that in the five experiments described by Gewirtz et al,24 the number of CFU-MK in control cultures was 11 1 SD colonies per 2 x lo5 cells, and the number of cells per colony was 6.1 3. In our experiments, we used both aplastic anemia sera and PHA-LCM to allow the cells to grow under an optimal culture condition.
PF4 is composed of four identical subunits of 70 amino acids, each subunit having a molecular weight of 7,767. The tetrameric molecular weight is 30,000. In blood circulation, PF4 is tightly bound to endothelial cells when released, and plasma levels usually are a t concentrations of nanograms per milliliter.25.26 Microgram quantities are, however, achievable In the marrow sinusoid, which does not in serum. 17, 19, 27, 28 freely communicate with plasma, local concentration of PF4 derived from the degeneration and release of mature megakaryocytes and platelets might be higher than that in circulation. We have shown that PF4 at a concentration of 2.5 pg/mL is able to inhibit megakaryocytopoiesis in vitro. 
